A New Theory of Enterorecirculation of Amino Acids and its use for Depleting Unwanted Amino Acids Using Oral Enzyme-Artificial Cells, as in Removing Phenylalanine in Phenylketonuria

References

• Chang I MS, Lister C. Plasma/Intestinal concentration patterns suggestive of entero-portal recirculation of amino acids: Effects of oral administration of asparaginase, glutaminase and tyrosinase immobilized by microencapsulation in artificial cells. J Biomat Artif Cells and Artif Organs 1989; 16: 147, 915–26
   Google Scholar
• Chang T MS, Bourget L, Lister C. Oral administration of microcapsules for removal of amino acids. 1992; 147: 641, US Patent No 5
   Google Scholar
• Scriver C. The Hyperphenylalaninemias. The Metabolic Basis of Inherited Disease6th Edition, CR Scriver, AL Beaudet, WS Sly, D. Valle. McGraw-Hill Co., New York 1989; Volume 1: 495–546
   Google Scholar
• Medical Research Council Working Party on Phenylketonuria. British Medical Journal 1993; 396: 115–119
   Google Scholar
• Chang T MS. Semipermeable microcapsules. Science 1964; 146: 524–525
   PubMed Web of Science ®Google Scholar
• Chang T MS, Macintosh F C, Mason SG. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 1966; 44: 115–128, 1966
   PubMed Web of Science ®Google Scholar
• Chang I MS. Artificial Cells. Charles C Thomas Publisher, SpringfieldUSA 1972; 1972, Monograph
   Google Scholar
• Chang I MS. Artificial Cells. Encyclopedia of Human Biology, Renalo Dulbecco. Academic Press, Inc., San Diego 1992; 388–383
   Google Scholar
• Chang I MS. Recent advances in artificial cells with emphasis on biotechnological and medical approaches based on microencapsulation. Chapter. Microcapsules and Nanoparticles in Medicine and Pharmacology, M Donbrow. CRC Press, USA 1992; 323–339, 1992
   Google Scholar
• Chang T MS, Poznansky MJ. Semipermeable microcapsules containing catalase for enzyme replacement in acatalsaemic mice. Nature 1968; 218(5138)242–245
   Web of Science ®Google Scholar
• Poznansky M J, Chang T MS. Comparison of the enzyme kinetics and immunological properties of catalase immobilized by microencapsulation and catalase in free solution for enzyme replacement. Biochim. Biophys. Acta 1974; 334: 103–115
   Web of Science ®Google Scholar
• Chang T MS. The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature 1971; 229(528)117–118
   PubMed Web of Science ®Google Scholar
• Bourget L, Chang T MS. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model. Biochim. Biophys. Acta. 1986; 883: 432–438
   PubMed Web of Science ®Google Scholar
• Hill DW, Walters FH, Wilson TD, Stuart JD. High performance liquid chromatography determination of amino acids in the pico-mole range. Analytical Chemistry 1979; 51(8)1338–1341
   PubMed Web of Science ®Google Scholar
• Greengard O, Dienel G, Delvalle J. Models for the Study of Inborn Errors of Metabolism, FA. Hommes. Elsevier/North-Holland Biomedical Press, Amsterdam 1979; 125–130
   Google Scholar
• Anderson A, Guroff G. Phenylketonuria. Comparative Pathology Bull. 1974; 6: 1–31
   Google Scholar
• Chang T MS. Microencapsulated multienzyme system. Methods in Enzymology 1988; 137: 444–457
   PubMed Web of Science ®Google Scholar
• Azakie A, Chang TMS, personal communication
   Google Scholar
• Zannoni V G, Weber WW, Van Valen P, Rubin Bernstein A.R., Dula BN. Phenylalanine metabolism and phenylketonuria in dilute-lethal mice. Genetics 1966; 54: 1391
   Google Scholar
• Shedlovsky A, McDonald J D, Symula D, Dove WF. Mouse Models of Human Phenylketonuria. Genetics 1993; 134: 1205–1210
   PubMed Web of Science ®Google Scholar
• Hoskins JA, Jack G., Wade HE, et al. Lancet 1980; 392–394
   Google Scholar
• Chang T MS. Preparation and characterization of xanthine oxidase immobilized by microencapsulation in artificial cells for the removal of hypoxanthine. J Biomat Artif Cells and Artif Organs 1989; 17: 611–16
   PubMed Web of Science ®Google Scholar
• Palmour R M, Goodyer P, Reade T, Chang T MS. Microencapsulated xanthine oxidase as experimental therapy in Lesch-Nyhan Disease. Lancet 1989; 2(8664)687–8
   PubMed Web of Science ®Google Scholar
• Kjellstrand C, Borges H, Pru C, Gardner D, Fink D. On the clinical use of microencapsulated zirconium phosphate-urease for the treatment of chronic uremia. Trans. Am. Soc. Artif. Intern. Organs 1981; 27: 24
   PubMedGoogle Scholar
• Shu C D, Chang T MS. Tyrosinase immobilized within artificial cells for detoxification in liver failure. II. In vivo studies in fulminant hepatic failure rats. Int. J. Artif. Organs 1981; 4: 82–84, 1981
   PubMed Web of Science ®Google Scholar
• Khanna R, Chang T MS. Characterization of L-histidine ammonialyase immobilized by microencapsulation in artificial cells: Preparation kinetics, stability, and in vitro depletion of histidine. Int. J. Art. Org. 1990; 13: 189–195
   PubMed Web of Science ®Google Scholar